Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 230,371,908 papers from all fields of science
Search
Sign In
Create Free Account
Quinolone Antibiotic
The basic structure of quinolone is nalidixic acid that has limited therapeutic value. However, the development of fluorinated quinolones led to new…
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Administration of aerosolized antibiotics in cystic fibrosis patients.
R. Moss
Chest
2001
Corpus ID: 5613397
High rates of colonization and the challenge of managing Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF…
Expand
2001
2001
Assessment of chronic toxicity and carcinogenicity in an accelerated cancer bioassay in rats of moxifloxacin, a quinolone antibiotic.
M. Iatropoulos
,
A. Jeffrey
,
H. Enzmann
,
E. von Keutz
,
G. Schlueter
,
G. Williams
Experimental and Toxicological Pathology
2001
Corpus ID: 46290893
The chronic toxicity and carcinogenicity of Moxifloxacin (MOX), a bacterial gyrase-inhibiting fluoroquinolone antibiotic, were…
Expand
1997
1997
Characterization and interconversion of polymorphs of premafloxacin, a new quinolone antibiotic.
W. C. Schinzer
,
M. S. Bergren
,
+4 authors
L. M. Madden
Journal of Pharmacy and Science
1997
Corpus ID: 38153347
The quinolone antibiotic premafloxacin crystallizes in at least five solid modifications, including three anhydrous phases (Forms…
Expand
1995
1995
Stereospecific high-performance liquid chromatographic assay of lomefloxacin in human plasma.
R. Foster
,
R. Carr
,
F. Pasutto
,
J. Longstreth
Journal of Pharmaceutical and Biomedical Analysis
1995
Corpus ID: 28321901
Highly Cited
1995
Highly Cited
1995
Pharmacokinetics and safety of trovafloxacin (CP-99, 219), a new quinolone antibiotic, following adminstration of single oral doses to healthy male volunteers
R. Teng
,
S. Harris
,
D. Nix
,
Jerome J. Schentag
,
G. Foulds
,
T. Liston
1995
Corpus ID: 73373662
Trovafloxacin (CP-99,219) is a new fluoroquinolone antibacterial agent with a broad spectrum of activity against Gram-positive…
Expand
1995
1995
Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers.
R. Teng
,
S. Harris
,
D. Nix
,
Jerome J. Schentag
,
G. Foulds
,
T. Liston
Journal of Antimicrobial Chemotherapy
1995
Corpus ID: 30930550
Trovafloxacin (CP-99,219) is a new fluoroquinolone antibacterial agent with a broad spectrum of activity against Gram-positive…
Expand
1995
1995
Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog.
L. Intorre
,
G. Mengozzi
,
M. Maccheroni
,
Simone Bertini
,
G. Soldani
Journal of Veterinary Pharmacology and…
1995
Corpus ID: 19539529
Enrofloxacin, a quinolone antibiotic developed exclusively for use in animals, was investigated for its effects on the steady…
Expand
1993
1993
Elimination of quinolone antibiotic carryover through use of antibiotic-removal beads
R. A. Zabinski
,
A. Larsson
,
K. Walker
,
S. Gilliland
,
J. Rotschafer
Antimicrobial Agents and Chemotherapy
1993
Corpus ID: 10485838
To prove the utility of antibiotic-removal beads in separating antibiotics from bacterial samples, Escherichia coli ATCC 25922…
Expand
1991
1991
Successful treatment of methicillin-resistant Staphylococcus aureus Keratitis with topical ciprofloxacin.
M. Insler
,
L. Fish
,
J. Silbernagel
,
J. A. Hobden
,
R. O'Callaghan
,
J. Hill
Ophthalmology (Rochester, Minn.)
1991
Corpus ID: 26944945
1991
1991
Ciprofloxacin interaction with sodium warfarin: a potentially dangerous side effect.
R. Renzi
,
S. Finkbeiner
American Journal of Emergency Medicine
1991
Corpus ID: 31122185
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE